Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis.
about
Association of toxicity of sorafenib and sunitinib for human keratinocytes with inhibition of signal transduction and activator of transcription 3 (STAT3)Small molecule targeted therapies for the second-line treatment for metastatic renal cell carcinoma: a systematic review and indirect comparison of safety and efficacy.In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013Axitinib in metastatic renal cell carcinoma: single center experience.Axitinib for the treatment of advanced renal cell carcinoma.First-line treatment in the management of advanced renal cell carcinoma: systematic review and network meta-analysis.Real-world costs and outcomes in metastatic renal cell carcinoma patients treated with targeted therapies: a cohort study from the French health insurance database.Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.Association of Single Nucleotide Polymorphisms in STAT3 with Hand-Foot Skin Reactions in Patients with Metastatic Renal Cell Carcinoma Treated with Multiple Tyrosine Kinase Inhibitors: A Retrospective Analysis in Japanese Patients.Indirect comparisons of efficacy and safety between seven newer targeted agents for metastatic renal cell carcinoma: A network meta-analysis of randomised clinical trials.Efficacy of targeted therapy for advanced renal cell carcinoma: a systematic review and meta-analysis of randomized controlled trials.
P2860
Q33889920-508CC49C-1578-4A25-910F-72E63C4963E4Q34371248-24DFFE65-941B-4537-B2A2-82A85EA62B3EQ36138388-F200DA0F-C198-437E-82F4-E7604F8AB89AQ37657679-E361A31E-A320-4CA9-BA6C-A67E4BCE027EQ38170397-68AB9E06-097F-48F5-98B9-3A4C60A9D457Q38550942-FA576B0F-08E2-4081-A40F-CB821C1C50C8Q38658255-54E015A6-33C6-444D-8740-78963C13E80CQ39013880-7369D355-813B-4AC1-8632-4F837276B863Q41458660-73CE4B9D-814E-4ECE-90C1-E5B4A4DBBBF8Q42743224-15BA7B54-5366-4AEE-9F99-C5FBEFF92AB1Q47358265-7607F460-5AD1-49DF-A3D6-77B6090A15DC
P2860
Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Second-line treatments for the ...... atic review and meta-analysis.
@en
type
label
Second-line treatments for the ...... atic review and meta-analysis.
@en
prefLabel
Second-line treatments for the ...... atic review and meta-analysis.
@en
P2093
P2860
P1476
Second-line treatments for the ...... atic review and meta-analysis.
@en
P2093
Abby Paine
Connie Chen
Grace Foley
Indra Tumur
James Larkin
Joseph C Cappelleri
Michel Kroes
Paul J Healey
Stephen Mitchell
P2860
P356
10.1517/14656566.2013.758713
P407
P577
2012-12-21T00:00:00Z